Dr. May on Olaratumab Activity in Pediatric Bone and Soft Tissue Sarcoma

Caitlin May, PhD, postdoctoral research fellowship at Eli Lilly and Company, discusses olaratumab's (Lartruvo) demonstrating anti-tumor activity in models of pediatric bone and soft-tissue sarcoma.

• শ্রেণী